Share on StockTwits

Omnicell (NASDAQ:OMCL) VP Nhat H. Ngo sold 2,274 shares of the stock on the open market in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $28.00, for a total value of $63,672.00. Following the completion of the transaction, the vice president now directly owns 45,985 shares of the company’s stock, valued at approximately $1,287,580. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Omnicell (NASDAQ:OMCL) traded up 0.56% during mid-day trading on Friday, hitting $28.52. The stock had a trading volume of 778,717 shares. Omnicell has a 52-week low of $19.29 and a 52-week high of $30.33. The stock has a 50-day moving average of $26.8 and a 200-day moving average of $26.88. The company has a market cap of $1.044 billion and a price-to-earnings ratio of 38.43.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.26 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.24 by $0.02. The company had revenue of $101.80 million for the quarter, compared to the consensus estimate of $97.49 million. During the same quarter last year, the company posted $0.21 earnings per share. Omnicell’s revenue was up 16.9% compared to the same quarter last year. Analysts expect that Omnicell will post $1.23 EPS for the current fiscal year.

A number of analysts have recently weighed in on OMCL shares. Analysts at Topeka Capital Markets initiated coverage on shares of Omnicell in a research note on Thursday, June 12th. They set a “buy” rating and a $30.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Omnicell in a research note on Thursday, May 29th. They now have a $28.00 price target on the stock. Finally, analysts at Stephens initiated coverage on shares of Omnicell in a research note on Tuesday, May 20th. They set an “overweight” rating on the stock. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $30.71.

Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.